Fujian Green Pine
300132
Yili Chuanning Biotechnology
301301
Shanghai Menon Animal Nutrition Technology
301156
4
Anhui Hyea Aromas
300886
5
Tuoxin Pharmaceutical Group
301089
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 6.02%98.27M | -24.86%443.03M | -29.33%307.89M | -12.18%192.25M | -19.65%92.69M | 5.66%589.59M | 15.70%435.7M | 6.26%218.91M | 35.37%115.36M | -13.56%558.01M |
Refunds of taxes and levies | ---- | 80.54%1.42M | 21.08%953.23K | 51.13%945.24K | 15.98%461.53K | -57.65%787.25K | -26.92%787.25K | -57.87%625.45K | 26.54%397.92K | -27.82%1.86M |
Cash received relating to other operating activities | 93.98%7.82M | -33.35%10.74M | -32.56%6.08M | -13.91%5.36M | -34.95%4.03M | -21.84%16.11M | -45.61%9.01M | -38.48%6.23M | 54.78%6.2M | -16.08%20.61M |
Cash inflows from operating activities | 9.17%106.1M | -24.95%455.19M | -29.31%314.92M | -12.05%198.56M | -20.31%97.19M | 4.48%606.49M | 13.01%445.5M | 3.74%225.76M | 36.21%121.96M | -13.70%580.48M |
Goods services cash paid | 25.00%83.85M | -7.26%247.68M | -9.66%173.54M | -4.43%119.84M | -11.65%67.08M | -9.58%267.08M | -5.23%192.09M | -8.83%125.39M | -2.62%75.93M | -24.32%295.37M |
Staff behalf paid | -7.46%22.54M | -3.07%84.63M | -1.11%63.72M | 2.42%45.19M | 1.15%24.36M | 2.28%87.31M | -0.36%64.43M | 0.50%44.13M | -4.74%24.08M | 13.14%85.36M |
All taxes paid | 11.99%8.7M | -9.25%38.09M | -22.76%24.83M | -2.63%17.13M | -25.02%7.77M | 17.81%41.98M | 50.05%32.15M | 31.84%17.59M | 24.37%10.36M | 22.58%35.63M |
Cash paid relating to other operating activities | 58.19%31.99M | -16.05%40.81M | -5.58%45.21M | -20.84%29.56M | -8.21%20.22M | -23.06%48.62M | -15.15%47.89M | -4.58%37.34M | -2.79%22.03M | 1.42%63.19M |
Cash outflows from operating activities | 23.15%147.08M | -7.59%411.22M | -8.69%307.3M | -5.67%211.72M | -9.80%119.43M | -7.21%444.99M | -2.51%336.56M | -4.05%224.45M | -1.37%132.4M | -13.92%479.55M |
Net cash flows from operating activities | -84.25%-40.98M | -72.77%43.97M | -93.01%7.62M | -1,103.00%-13.16M | -113.03%-22.24M | 60.02%161.5M | 122.39%108.94M | 108.06%1.31M | 76.65%-10.44M | -12.66%100.93M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | --4.5M | -92.85%1.97M | --3.86M | --962.58K | ---- | --27.5M | ---- | ---- | ---- | ---- |
Cash received from returns on investments | -8.19%1.42M | 71.79%10.71M | 723.84%6.77M | 591.74%4.92M | --1.54M | 2.54%6.24M | --822.36K | --711.53K | ---- | --6.08M |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | -96.48%23.5K | 391.88%3.4M | ---- | ---- | 167.49%667.54K | 47.55%692K | -81.01%260K | --190K | 13,389.60%249.56K |
Net cash received from disposal of subsidiaries and other business units | ---- | --1.6M | ---- | ---- | ---- | ---- | --26.5M | ---- | ---- | ---- |
Cash received relating to other investing activities | 47.72%640.22M | 19.24%1.3B | 77.45%1.34B | 82.91%931.03M | 66.05%433.4M | 195.91%1.09B | 325.99%754M | 271.53%509M | 47.46%261M | 60.43%369M |
Cash inflows from investing activities | 48.56%646.14M | 16.87%1.32B | 72.89%1.35B | 83.72%936.92M | 66.52%434.94M | 200.09%1.13B | 340.65%782.01M | 268.56%509.97M | 47.44%261.19M | 63.19%375.33M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | -77.11%744.18K | -65.39%8.72M | -48.09%8.81M | -24.14%5.19M | -26.19%3.25M | 26.55%25.2M | -22.92%16.97M | -59.28%6.84M | -44.09%4.4M | -58.92%19.92M |
Cash paid to acquire investments | --37.5M | 32.50%1.33M | 27.50%1.28M | ---- | ---- | -76.19%1M | -76.19%1M | -68.75%1M | -37.50%1M | 7.69%4.2M |
Net cash paid to acquire subsidiaries and other business units | --4M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash paid relating to other investing activities | 72.85%642.04M | 18.73%1.36B | 95.54%1.27B | 113.09%941.84M | 67.32%371.45M | 163.06%1.14B | 147.71%649M | 142.86%442M | 93.04%222M | 25.07%434M |
Cash outflows from investing activities | 82.62%684.28M | 16.92%1.37B | 91.79%1.28B | 110.53%947.03M | 64.77%374.7M | 154.93%1.17B | 131.42%666.97M | 122.69%449.84M | 82.69%227.4M | 14.71%458.12M |
Net cash flows from investing activities | -163.31%-38.14M | -18.48%-49.25M | -36.68%72.85M | -116.82%-10.12M | 78.32%60.24M | 49.79%-41.57M | 203.89%115.05M | 194.50%60.13M | -35.86%33.79M | 51.12%-82.79M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | 815.67%2.75M | --87K | --87K | ---- | -95.01%300K | ---- | ---- | ---- | 85.08%6.02M |
-Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | ---- | --87K | --87K | ---- | -95.01%300K | ---- | ---- | ---- | 85.08%6.02M |
Cash from borrowing | ---- | -98.68%10K | -98.68%10K | -98.68%10K | ---- | -98.10%760K | -98.10%760K | -98.10%760K | -96.20%760K | -63.64%40M |
Cash received relating to other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -7.87%5.17M | -9.54%3.3M | --1.96M | ---- |
Cash inflows from financing activities | ---- | 160.09%2.76M | -98.36%97K | -97.61%97K | ---- | -97.70%1.06M | -88.52%5.93M | -91.80%4.06M | -89.09%2.72M | -87.33%46.02M |
Borrowing repayment | ---- | --761.67K | --761.67K | --760K | ---- | ---- | ---- | ---- | ---- | -74.40%50M |
Dividend interest payment | 99.39%7.49M | 32.05%23.08M | 32.12%23.08M | 32.19%23.08M | 87.84%3.76M | 19.87%17.48M | 19.83%17.47M | 21.05%17.46M | 56.95%2M | 4.79%14.58M |
Cash payments relating to other financing activities | ---- | -11.72%3.21M | -40.25%1.45M | -27.77%1.16M | 1.70%823.3K | 19.27%3.63M | -3.63%2.43M | -36.42%1.6M | --809.54K | -6.77%3.05M |
Cash outflows from financing activities | 63.56%7.49M | 28.12%27.05M | 27.11%25.29M | 31.14%25M | 63.02%4.58M | -68.78%21.11M | -70.34%19.9M | -29.25%19.06M | -75.08%2.81M | -68.17%67.63M |
Net cash flows from financing activities | -63.56%-7.49M | -21.15%-24.29M | -80.35%-25.2M | -65.93%-24.9M | -4,830.43%-4.58M | 7.22%-20.05M | 9.72%-13.97M | -166.65%-15.01M | -100.68%-92.91K | -114.35%-21.61M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | 174.89%269.19K | 1,225.30%458.3K | -191.87%-136.35K | -52.01%105.04K | -436.18%-359.44K | -97.87%34.58K | 1,690.02%148.43K | -73.12%218.89K | ---67.04K | 531.66%1.62M |
Net increase in cash and cash equivalents | -361.15%-86.34M | -129.14%-29.11M | -73.76%55.14M | -203.03%-48.07M | 42.61%33.06M | 5,496.95%99.91M | 372.15%210.16M | 182.44%46.65M | 7.39%23.18M | -101.92%-1.85M |
Add:Begin period cash and cash equivalents | -12.14%210.09M | 71.76%239.14M | 71.76%239.14M | 71.76%239.14M | 71.76%239.14M | -1.31%139.22M | -1.31%139.22M | -1.31%139.22M | -1.31%139.22M | 215.56%141.07M |
End period cash equivalent | -54.54%123.75M | -12.17%210.02M | -15.77%294.27M | 2.79%191.06M | 67.60%272.2M | 71.76%239.14M | 447.19%349.39M | 120.02%185.88M | -0.16%162.41M | -1.31%139.22M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.